| SC 13G/A | 2022-02-03 | BlackRock Inc. | 10x Genomics, Inc. | 8,018,634 | 8.8% | EDGAR |
| SC 13G | 2022-01-18 | BAILLIE GIFFORD & CO | 10x Genomics, Inc. | 6,878,377 | 7.5% | EDGAR |
| SC 13G/A | 2021-12-10 | FMR LLC | 10x Genomics, Inc. | 13,746,514 | 14.1% | EDGAR |
| SC 13D/A | 2021-07-30 | Saxonov Serge | 10x Genomics, Inc. | 4,851,530 | 5.3% | EDGAR |
| SC 13D/A | 2021-07-30 | Hindson Benjamin J. | 10x Genomics, Inc. | 3,611,410 | 4.0% | EDGAR |
| SC 13G/A | 2021-02-16 | Foresite Capital Fund I, L.P. | 10x Genomics, Inc. | 1,250,000 | 1.6% | EDGAR |
| SC 13G/A | 2021-02-16 | Venrock Associates VI, L.P. | 10x Genomics, Inc. | 7,828,247 | 9.1% | EDGAR |
| SC 13G/A | 2021-02-16 | Meritech Capital Partners V L.P. | 10x Genomics, Inc. | 2,104,329 | 2.6% | EDGAR |
| SC 13G/A | 2021-02-16 | SB INVESTMENT ADVISERS (UK) LTD | 10x Genomics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-12 | Paladin Capital Management, LLC | 10x Genomics, Inc. | 2,028,052 | 2.5% | EDGAR |
| SC 13G/A | 2021-02-10 | MORGAN STANLEY | 10x Genomics, Inc. | 5,915,534 | 7.4% | EDGAR |
| SC 13G | 2021-02-10 | VANGUARD GROUP INC | 10x Genomics, Inc. | 6,187,705 | 7.7% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | 10x Genomics, Inc. | 16,661,816 | 19.2% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | 10x Genomics, Inc. | 5,163,020 | 6.4% | EDGAR |
| SC 13G/A | 2020-05-11 | FMR LLC | 10x Genomics, Inc. | 12,141,192 | 18.7% | EDGAR |
| SC 13G/A | 2020-05-08 | MORGAN STANLEY | 10x Genomics, Inc. | 6,792,818 | 12.1% | EDGAR |
| SC 13G/A | 2020-04-09 | MORGAN STANLEY | 10x Genomics, Inc. | 5,018,246 | 23.6% | EDGAR |
| SC 13G | 2020-02-18 | Paladin Capital Management, LLC | 10x Genomics, Inc. | 6,528,052 | 23.8% | EDGAR |
| SC 13G | 2020-02-14 | Foresite Capital Fund I, L.P. | 10x Genomics, Inc. | 7,235,396 | 25.9% | EDGAR |
| SC 13G | 2020-02-14 | Meritech Capital Partners V L.P. | 10x Genomics, Inc. | 2,984,864 | 12.5% | EDGAR |